Myasthenia gravis is an autoimmune neuromuscular disorder caused by antibodies against acetylcholine receptors at the neuromuscular junction, reducing their availability and impairing muscle contraction. Symptoms include fatigue and weakness of eye muscles, facial muscles, and limbs that worsens with activity and improves with rest. Diagnosis involves tensilon testing and antibody detection, while treatment consists of acetylcholinesterase inhibitors, immunosuppressants, thymectomy, and management of symptoms. Prognosis depends on individual factors, but remission is possible in some cases.